Name
Intellia Therapeutics, Inc.
Company Description
Intellia Therapeutics, Inc. is a clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Leveraging gene editing technology, Intellia is developing novel, first-in-class medicines to meet important unmet needs and advance treatments for patients.
Website
Featured Exhibitor
Yes
Address
40 Erie Street, Suite 130
Cambridge, MA 02139
United States
Cambridge, MA 02139
United States
